Skin cancers are highly prevalent malignancies that affect millions of people worldwide.
These include melanomas and nonmelanoma skin cancers. Melanomas are among the …

Skin cancer is one of the most common forms of cancer. Several million people are
estimated to have affected with this condition worldwide. Skin cancer generally includes …

Drug repurposing is the process of developing existing or abandoned drugs for a different
disease. Repurposing can circumvent higher costs and times associated with conventional …

Cutaneous malignancies are classified into melanoma and non-melanoma skin cancers (1).
Cutaneous melanoma is responsible for the majority of deaths from skin cancers with …

The withdrawal of several blockbuster drugs due to severe adverse effects and the failure of
several developed drugs in clinical trials raised questions about the efficacy of current …

Nowadays, oncogene‐directed therapy and immunotherapy represent the two most
promising avenues for patients with metastatic melanoma. The recent oncogene‐directed …

Skin cancers are by far the most common malignancy of humans, particularly in the white
population. The growing incidence of cutaneous malignancies has heralded the need for …

Drug repurposing is a strategy consisting of finding new indications for already known
marketed drugs used in various clinical settings or highly characterized compounds despite …

Skin cancer (SC) poses a global threat to the healthcare system and is expected to increase
significantly over the next two decades if not diagnosed at an early stage. Early diagnosis is …

The melanoma field has seen an unprecedented set of clinical advances over the past
decade. Therapeutic efficacy for advanced or metastatic melanoma went from being one of …